These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 24387665)

  • 1. Update on diagnostic and treatment of uncomplicated and complicated malaria in adults and selected vulnerable populations.
    Botha P; Bottieau E; Uthman O; Obike U; Nachega JB
    Infect Disord Drug Targets; 2013 Aug; 13(4):278-91. PubMed ID: 24387665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. UK malaria treatment guidelines.
    Lalloo DG; Shingadia D; Pasvol G; Chiodini PL; Whitty CJ; Beeching NJ; Hill DR; Warrell DA; Bannister BA;
    J Infect; 2007 Feb; 54(2):111-21. PubMed ID: 17215045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Artesunate-mefloquine versus chloroquine for treatment of uncomplicated Plasmodium knowlesi malaria in Malaysia (ACT KNOW): an open-label, randomised controlled trial.
    Grigg MJ; William T; Menon J; Dhanaraj P; Barber BE; Wilkes CS; von Seidlein L; Rajahram GS; Pasay C; McCarthy JS; Price RN; Anstey NM; Yeo TW
    Lancet Infect Dis; 2016 Feb; 16(2):180-188. PubMed ID: 26603174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Artemisinin derivatives and malaria: useful, in combination with other antimalarials.
    Prescrire Int; 2008 Aug; 17(96):162-8. PubMed ID: 19492494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions between malaria and human immunodeficiency virus anno 2014.
    Van Geertruyden JP
    Clin Microbiol Infect; 2014 Apr; 20(4):278-85. PubMed ID: 24528518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Treatment of Plasmodium knowlesi Malaria.
    Barber BE; Grigg MJ; William T; Yeo TW; Anstey NM
    Trends Parasitol; 2017 Mar; 33(3):242-253. PubMed ID: 27707609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The clinical impact of artemisinin resistance in Southeast Asia and the potential for future spread.
    Woodrow CJ; White NJ
    FEMS Microbiol Rev; 2017 Jan; 41(1):34-48. PubMed ID: 27613271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malaria: An Update.
    Basu S; Sahi PK
    Indian J Pediatr; 2017 Jul; 84(7):521-528. PubMed ID: 28357581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective comparative study of knowlesi, falciparum, and vivax malaria in Sabah, Malaysia: high proportion with severe disease from Plasmodium knowlesi and Plasmodium vivax but no mortality with early referral and artesunate therapy.
    Barber BE; William T; Grigg MJ; Menon J; Auburn S; Marfurt J; Anstey NM; Yeo TW
    Clin Infect Dis; 2013 Feb; 56(3):383-97. PubMed ID: 23087389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical pharmacology of artemisinin-based combination therapies.
    German PI; Aweeka FT
    Clin Pharmacokinet; 2008; 47(2):91-102. PubMed ID: 18193915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High risk of neutropenia in HIV-infected children following treatment with artesunate plus amodiaquine for uncomplicated malaria in Uganda.
    Gasasira AF; Kamya MR; Achan J; Mebrahtu T; Kalyango JN; Ruel T; Charlebois E; Staedke SG; Kekitiinwa A; Rosenthal PJ; Havlir D; Dorsey G
    Clin Infect Dis; 2008 Apr; 46(7):985-91. PubMed ID: 18444813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malaria: an update for physicians.
    Nadjm B; Behrens RH
    Infect Dis Clin North Am; 2012 Jun; 26(2):243-59. PubMed ID: 22632637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malaria.
    Fletcher TE; Beeching NJ
    J R Army Med Corps; 2013 Sep; 159(3):158-66. PubMed ID: 24109136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Artemisinin-based combination therapy for treating uncomplicated Plasmodium vivax malaria.
    Sinclair D; Gogtay N; Brand F; Olliaro P
    Cochrane Database Syst Rev; 2011 Jul; (7):CD008492. PubMed ID: 21735431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiretroviral Choice for HIV Impacts Antimalarial Exposure and Treatment Outcomes in Ugandan Children.
    Parikh S; Kajubi R; Huang L; Ssebuliba J; Kiconco S; Gao Q; Li F; Were M; Kakuru A; Achan J; Mwebaza N; Aweeka FT
    Clin Infect Dis; 2016 Aug; 63(3):414-22. PubMed ID: 27143666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Artesunate. A review of its pharmacology and therapeutic efficacy in the treatment of malaria.
    Barradell LB; Fitton A
    Drugs; 1995 Oct; 50(4):714-41. PubMed ID: 8536555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Artemisinins.
    Woodrow CJ; Haynes RK; Krishna S
    Postgrad Med J; 2005 Feb; 81(952):71-8. PubMed ID: 15701735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malaria Surveillance - United States, 2015.
    Mace KE; Arguin PM; Tan KR
    MMWR Surveill Summ; 2018 May; 67(7):1-28. PubMed ID: 29723168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Artesunate versus quinine for treating severe malaria.
    Jones KL; Donegan S; Lalloo DG
    Cochrane Database Syst Rev; 2007 Oct; (4):CD005967. PubMed ID: 17943870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ferroquine and artesunate in African adults and children with Plasmodium falciparum malaria: a phase 2, multicentre, randomised, double-blind, dose-ranging, non-inferiority study.
    Held J; Supan C; Salazar CL; Tinto H; Bonkian LN; Nahum A; Moulero B; Sié A; Coulibaly B; Sirima SB; Siribie M; Otsyula N; Otieno L; Abdallah AM; Kimutai R; Bouyou-Akotet M; Kombila M; Koiwai K; Cantalloube C; Din-Bell C; Djeriou E; Waitumbi J; Mordmüller B; Ter-Minassian D; Lell B; Kremsner PG
    Lancet Infect Dis; 2015 Dec; 15(12):1409-19. PubMed ID: 26342427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.